# A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

> **NCT05203692** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 80 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** DS-7011a
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05203692
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-02
- **Primary completion:** 2023-01-25
- **Final completion:** 2023-03-22
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05203692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05203692, "A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05203692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*